Page 1 | Search Results | Blood Advances | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses

Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, Barbara Mora, Emmanuelle Verger, Nabih Maslah, Aurelie Plessier, Pierre-Emmanuel Rautou, Isabelle Ollivier-Hourman, Victor De Ledinghen, Odile Goria, Christophe Bureau, Claudia Siracusa, Dominique Valla, Stephane Giraudier, Francesco Passamonti, Jean-Jacques Kiladjian

Blood Adv (2020) 4 (15): 3708–3715.

https://doi.org/10.1182/bloodadvances.2020002414

Published: 2020

Includes: Supplemental data

Journal Articles

Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro

Jan Habbel, Lucas Arnold, Yiyang Chen, Michael Möllmann, Kirsten Bruderek, Sven Brandau, Ulrich Dührsen, Maher Hanoun

Blood Adv (2020) 4 (13): 3000–3010.

https://doi.org/10.1182/bloodadvances.2019001292

Published: 2020

Includes: Supplemental data

Journal Articles

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel-Angel Perales, Yi-Bin Chen, Gabrielle Meyers, John F. DiPersio

Blood Adv (2020) 4 (8): 1656–1669.

https://doi.org/10.1182/bloodadvances.2019001043

Published: 2020

Includes: Supplemental data

Journal Articles

Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B

Carolina R. Batista, Michelle Lim, Anne-Sophie Laramée, Faisal Abu-Sardanah, Li S. Xu, Rajon Hossain, Gillian I. Bell, David A. Hess, Rodney P. DeKoter

Blood Adv (2018) 2 (21): 2798–2810.

https://doi.org/10.1182/bloodadvances.2018019950

Published: 2018

Includes: Supplemental data

Journal Articles

Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways

Sheryl M. Gough, Liat Goldberg, Marbin Pineda, Robert L. Walker, Yuelin J. Zhu, Sven Bilke, Yang Jo Chung, Joseph Dufraine, Subhadip Kundu, Elad Jacoby, Terry J. Fry, Susanna Fischer, Renate Panzer-Grümayer, Paul S. Meltzer, Peter D. Aplan

Blood Adv (2017) 1 (20): 1749–1759.

https://doi.org/10.1182/bloodadvances.2017009837

Published: 2017

Includes: Supplemental data

NARROW

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses

Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B

Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways

Email alerts

ASH Publications

American Society of Hematology

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses

Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B

Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only